Bafna Pharmaceuticals Limited BAFNAPH.NS
Full chart
Set alert
430.20 INR -8.75 (-1.99%)
Nov 3, 2026, 4:44 AM EST
430.20 Day range 430.20
94.77 52-week range 479.95
- YTD
- +189.91%
- 1 year
- +171.69%
1Y chart
Signals (48)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 27, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 25, 2026 | 1 week ago |
| MACD: Buy Signal | Sep 20, 2026 | 1 month ago |
| RSI: Overbought | Sep 20, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Aug 30, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 27, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 19, 2026 | 3 months ago |
| RSI: Overbought | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| RSI: Overbought | Jun 28, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| RSI: Overbought | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 31, 2026 | 5 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 7 months ago |
Newest 20 of 48.
Compare BAFNAPH.NS
Chart and line up BAFNAPH.NS against other symbols or a saved comparison set.
- BAFNAPH.NS Bafna Pharmaceuticals Limited
430.20
-8.75 -1.99%
- SPY State Street SPDR S&P 500 ETF Trust
754.35
+2.25 +0.30%
- QQQ Invesco QQQ Trust
685.28
+4.19 +0.62%
Sign in to keep these symbols in a saved comparison set.
| Metric | BAFNAPH.NS | SPY | QQQ |
|---|---|---|---|
| Last price | 430.20 | 754.35 | 685.28 |
| Change | -8.75 | +2.25 | +4.19 |
| Change % | -1.99% | +0.299162% | +0.61519% |
| Open | 430.20 | 752.73 | 684.39 |
| Day high | 430.20 | 757.07 | 688.69 |
| Day low | 430.20 | 752.41 | 683.18 |
| Previous close | 438.95 | 752.10 | 681.09 |
| Volume | 15.20K | 32.89M | 37.52M |
| Average volume | 17.85K | 41.32M | 35.27M |
| Market cap | 10.18B | 795.18B | 457.52B |
| P/E ratio | 130.76 | 23.95 | 26.24 |
| Earnings per share | 3.29 | 31.50 | 26.12 |
| Dividend yield | — | 0.00 | 0.00 |
| 52-week high | 479.95 | 781.62 | 762.86 |
| 52-week low | 94.77 | 629.28 | 555.60 |
| 1-week return | -4.74% | -1.99% | -4.99% |
| 1-month return | +13.58% | -1.99% | -8.58% |
| 3-month return | +57.27% | -0.438185% | -2.11% |
| 6-month return | +218.83% | +4.68% | +1.65% |
| Year-to-date return | +189.91% | +10.62% | +11.55% |
| 1-year return | +171.69% | +10.39% | +8.42% |
| 2-year return | +426.17% | +32.39% | +41.00% |
| 50-day moving average | 360.40 | 767.22 | 724.35 |
| 200-day moving average | 208.61 | 729.15 | 679.82 |
| Target price | — | — | — |
| Beta | — | 1.00 | 1.22 |
| Short ratio | — | — | — |
| Institutional ownership | — | — | — |